fbpx Skip to main content

FRIDAY, Oct. 2, 2020 (HealthDay News) — There is considerable state-level variation in the prevalence of eclampsia, according to a study published online Oct. 1 in JAMA Network Open.

Alexander J. Butwick, M.B.B.S., from the Stanford University School of Medicine in California, and colleagues examined the extent of statewide variation in the prevalence of chronic hypertension, hypertensive disorders of pregnancy, and eclampsia in the United States in a cross-sectional study using 2017 U.S. birth certificate data. Data were included for 3,659,553 women.

The researchers found the lowest prevalence of chronic hypertension in Hawaii, while the highest was seen in Alaska (1.0 and 3.4 percent, respectively). The prevalence of hypertensive disorders of pregnancy varied from 4.3 percent in Massachusetts to 9.3 percent in Louisiana. Delaware and Hawaii had the lowest and highest adjusted prevalence of eclampsia (0.03 and 2.8 percent, respectively). There was high statewide variation observed for eclampsia (median odds ratio, 2.36), indicating that the median odds of eclampsia were higher if the same women delivered in a U.S. state with higher versus lower eclampsia prevalence. There was modest variation noted between states in chronic hypertension and hypertensive disorders of pregnancy (median odds ratios, 1.27 and 1.17, respectively).

“These data can inform future public health inquiries to identify reasons for the state-level variability in eclampsia prevalence,” the authors write.

Abstract/Full Text


You May Also Like::  Sleeve Gastrectomy Yields Larger Long-Term Weight Loss Than RYGB

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More